Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
5.90
+0.14 (2.43%)
At close: Jun 1, 2026, 4:00 PM EDT
5.81
-0.09 (-1.53%)
After-hours: Jun 1, 2026, 6:02 PM EDT
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $101.35 million as of June 1, 2026. Its market cap has increased by 104.71% in one year.
Market Cap
101.35M
Enterprise Value
82.20M
1-Year Change
104.71%
Ranking
Category
Stock Price
$5.90
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.56M to $101.35M, a decrease of -76.78%. That is a compound annual growth rate of -16.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 98.95M | -25.53% |
| Dec 31, 2025 | 132.88M | 109.60% |
| Dec 31, 2024 | 63.40M | -79.41% |
| Dec 29, 2023 | 307.91M | 172.47% |
| Dec 30, 2022 | 113.01M | -55.17% |
| Dec 31, 2021 | 252.07M | -15.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aldeyra Therapeutics | 105.56M |
| Seer, Inc. | 105.51M |
| Cognition Therapeutics | 105.44M |
| PepGen | 103.75M |
| Rein Therapeutics | 103.27M |
| Biomea Fusion | 99.77M |
| Adicet Bio | 97.76M |
| ProMIS Neurosciences | 96.94M |